Ticker: HALO

Company: HALOZYME THERAPEUTICS INC

Person: Bernadette Connaughton, director

Transaction date: May 1, 2026

Reporting date: May 5, 2026

Average share price: 63.48

Sold 1625.0 shares for 103155.0